Alnylam Pharmaceuticals Ownership | Who Owns Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals Ownership Summary
Alnylam Pharmaceuticals is owned by 69.96% institutional investors, 0.42% insiders, and 29.62% retail investors. Fmr is the largest institutional shareholder, holding 12.93% of ALNY shares. Capital Group Growth Fnd of Amer Comp is the top mutual fund, with 7.40% of its assets in Alnylam Pharmaceuticals shares.
ALNY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Alnylam Pharmaceuticals | 69.96% | 0.42% | 29.62% |
| Sector | Healthcare Stocks | 231.98% | 10.74% | -142.72% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 16.77M | 12.93% | $7.65B |
| Capital world investors | 16.30M | 12.40% | $6.48B |
| Vanguard group | 13.55M | 10.31% | $5.39B |
| Blackrock funding, inc. /de | 10.40M | 7.91% | $4.14B |
| Blackrock | 9.55M | 7.57% | $2.32B |
| Capital research global investors | 6.78M | 5.16% | $2.70B |
| Jpmorgan chase | 4.72M | 3.59% | $1.88B |
| State street | 3.08M | 2.38% | $1.41B |
| Geode capital management | 2.65M | 2.02% | $1.06B |
| Baillie gifford | 2.60M | 1.98% | $1.03B |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fenghe fund management pte. | 218.70K | 4.90% | $86.97M |
| Bellevue group | 446.52K | 4.23% | $203.61M |
| Parkman healthcare partners | 87.69K | 4.17% | $39.99M |
| Orbis allan gray | 1.95M | 3.82% | $889.64M |
| Rosenblum silverman sutton s f inc /ca | 34.00K | 3.54% | $15.50B |
| Orbimed advisors | 301.60K | 3.24% | $137.53M |
| Palo alto investors lp | 32.32K | 2.73% | $14.74M |
| Artia global partners lp | 34.57K | 2.50% | $15.76M |
| Quantessence capital | 15.87K | 2.29% | $7.24M |
| 683 capital management | 122.90K | 2.26% | $29.86M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 2.25M | 0.10% | 2.25M |
| Arrowstreet capital, limited partnership | 1.36M | 0.39% | 1.19M |
| Fmr | 16.77M | 0.40% | 961.10K |
| Qube research | 811.28K | 0.38% | 811.28K |
| Two sigma advisers, lp | 892.50K | 0.81% | 626.40K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 2.17M | 0.61% | -2.11M |
| Regeneron pharmaceuticals | - | - | -1.39M |
| Price t rowe associates inc /md/ | 1.80M | 0.09% | -1.34M |
| Dodge & cox | 2.32M | 0.57% | -875.87K |
| Jane street group | 311.29K | 0.02% | -647.46K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 2.25M | 0.10% | 2.25M | $895.82M |
| Susquehanna advisors group | 286.10K | 2.00% | 286.10K | $130.46M |
| Fenghe fund management pte. | 218.70K | 4.90% | 218.70K | $86.97M |
| Bank of america corp /de/ | 83.50K | 0.00% | 83.50K | $20.29M |
| Axa investment managers | 61.66K | 0.08% | 61.66K | $28.12M |
Sold Out
| Holder | Change |
|---|---|
| Rise advisors | -1.00 |
| Financial gravity asset management | -1.00 |
| Salem investment counselors | -1.00 |
| Bear mountain capital | -1.00 |
| Kohmann bosshard financial services | -1.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 684 | -20.56% | 91,965,556 | -31.27% | 69 | 0.66% | 343 | -32.61% | 232 | 5.45% |
| Sep 30, 2025 | 822 | 19.83% | 128,435,377 | -3.80% | 99 | 0.93% | 481 | 36.26% | 215 | -3.15% |
| Jun 30, 2025 | 685 | 2.09% | 133,478,551 | 3.70% | 102 | 1.04% | 354 | 1.14% | 220 | 10.00% |
| Mar 31, 2025 | 28 | -95.52% | 1,770,848 | -98.63% | 1 | 0.01% | 11 | -96.63% | 10 | -94.71% |
| Dec 31, 2024 | 603 | -0.33% | 129,230,860 | 5.02% | 100 | 1.10% | 315 | -2.78% | 183 | 6.40% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Capital Group Growth Fnd of Amer Comp | 9.82M | 7.40% | -120.09K |
| American Funds Growth Fund of Amer A | 9.82M | 7.40% | -120.09K |
| Vanguard US Total Market Shares ETF | 4.07M | 3.15% | 54.28K |
| Vanguard Total Stock Mkt Idx Inv | 4.17M | 3.14% | 9.04K |
| VA CollegeAmerica Amcap 529A | 3.73M | 2.89% | 658.62K |
| Vanguard Mid Cap Index Institutional | 2.86M | 2.16% | -14.93K |
| Invesco QQQ Trust | 2.83M | 2.13% | -6.26K |
| American Funds New Perspective A | 2.39M | 1.80% | -370.32K |
| Capital Group New Perspective Comp | 2.39M | 1.80% | -370.32K |
| Capital Group AMCAP Composite | 2.21M | 1.67% | -188.64K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 02, 2026 | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $176.80K |
| Mar 02, 2026 | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $21.04K |
| Mar 02, 2026 | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $115.92K |
| Mar 02, 2026 | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $40.26K |
| Mar 02, 2026 | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $148.76K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 180 |
| 2025 Q4 | - | 96 |
| 2025 Q3 | - | 80 |
| 2025 Q2 | - | 17 |
| 2025 Q1 | - | 152 |
ALNY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools